Whitepaper: USP method modernisation
Posted: 8 December 2021 | Thermo Fisher Scientific | No comments yet
The incorporation of IC to the USP offers a great potential to reduce the number of tests from five to two and significantly simplify any such monograph. Such opportunities not only offer analysts a significant reduction in the number of tests but also introduce the reliability and reproducibility required in a modern GMP laboratory, namely retention time reproducibility, time and cost savings, and overall reduction in user training and system maintenance needs.
Related content from this organisation
Related topics
Analytical techniques, Biologics, Biopharmaceuticals, Chromatography, Data integrity, Drug Delivery Systems, Excipients, Formulation, Good Manufacturing Practice (GMP), Ingredients, Lab Automation, Manufacturing, Outsourcing, QA/QC, Regulation & Legislation, Research & Development (R&D)